Curis, Inc. CRIS
0.83
(0.05)
(5.68%)
as of 25 Sep
- Market cap
- $1.8M
- P/E
- 0.0×
Follow CRIS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 455.35% | (693.95%) | 2,829.10% | 312.10% |
+8 more TTM periods Free account |
|
| (87.76%) | (61.34%) | (24.77%) | (104.28%) | ||
ROIC |
0.00% | 0.00% | (890.43%) | 0.00% | |
Return on Tangible Assets |
306.34% | (1,251.63%) | 106.80% | 618.86% | |
Average Days of Receivables |
— | — | 0.00 | 101.60 | |
Free Cash Flow per Share |
(14.32) | (29.90) | (41.33) | (38.38) | |
Free Cash Flow |
(30.59) | (28.95) | (27.20) | (30.09) | |
Piotroski F-Score |
— | — | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(296.62%) | (104.48%) | (258.49%) | 533.51% | |
Accounts Receivable Turnover |
— | — | 0.00 | 3.75 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.02 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 26,168.15 | |
Days of Inventory on Hand |
— | — | — | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 299.21% | 269.50% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 148.75% | 124.61% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 42.55% | 38.65% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.45 | 1.37 | 3.59 | 0.82 | |
Depreciation/Fixed assets |
1.83 | 2.19 | 2.73 | 5.89 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 14.35 | 14.86 | |
Operating CF per Share |
(14.32) | (29.90) | (41.33) | (38.38) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | (80.29%) | (313.79%) |
Columns are period end dates